Both Ukraine and Russia are major centres for international clinical research, with many multinational pharmaceutical clinical trials taking place in these countries. The Russian invasion of Ukraine and the resulting war and sanctions regime have resulted in significant disruption to the conduct of such trials and the availability of medication for trial patients. Download this report from Sterling to discover..
- How the war in Ukraine is affecting the conduct of clinical trials
- Regulatory responses to the disruption of clinical trials
- Actions that trial sponsors are taking to try to mitigate clinical trial disruption
- The impact of sanctions on Russia
- The consequences for drug development and access to new medicines for patients
